Sera Prognostics Inc (SERA) USD0.0001 A
Sell:$1.99Buy:$5.70
$0.31
(5.88%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$1.99
Buy:$5.70
Change:$0.31
(5.88%)
$0.31
(5.88%)Prices delayed by at least 15 minutes
Sell:$1.99
Buy:$5.70
Change:$0.31
(5.88%)
$0.31
(5.88%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 14 January 2025 | Benjamin Giessinger JacksonGeneral Counsel | Sell Regular sell transaction (market) | 8,407 | $6.20 | $52,123.40 | 112,154 |
| 14 January 2025 | CATALYST HEALTH VENTURES LPVenture Capital | Sell Regular sell transaction (market) | 2 | $6.29 | $12.58 | 0 |
| 14 January 2025 | CATALYST HEALTH VENTURES LPVenture Capital | Sell Regular sell transaction (market) | 1,814 | $6.29 | $11,410.06 | 0 |
| 14 January 2025 | CATALYST HEALTH VENTURES LPVenture Capital | Sell Regular sell transaction (market) | 2,695 | $6.29 | $16,951.55 | 0 |
| 14 January 2025 | CATALYST HEALTH VENTURES LPVenture Capital | Sell Regular sell transaction (market) | 4,827 | $6.29 | $30,361.83 | 0 |
| 13 January 2025 | Benjamin Giessinger JacksonGeneral Counsel | Sell Regular sell transaction (market) | 7,912 | $6.38 | $50,478.56 | 120,561 |
| 13 January 2025 | Robert Gardner HarrisonChief Information Officer | Sell Regular sell transaction (market) | 2,264 | $6.47 | $14,648.08 | 114,573 |
| 13 January 2025 | CATALYST HEALTH VENTURES LPVenture Capital | Sell Regular sell transaction (market) | 6,287 | $6.39 | $40,173.93 | 4,827 |
| 13 January 2025 | CATALYST HEALTH VENTURES LPVenture Capital | Sell Regular sell transaction (market) | 3,458 | $6.39 | $22,096.62 | 2,695 |
| 13 January 2025 | CATALYST HEALTH VENTURES LPVenture Capital | Sell Regular sell transaction (market) | 2,415 | $6.39 | $15,431.85 | 1,814 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 27 March 2024 | John J. (Jay) BonifaceChief Level Officer | Sell Option/Award related | 48,909 | $9.62 | $470,504.58 | 139,771 |
| 26 March 2024 | Zhenya LindgardtDirector | Sell Tax related | 38,899 | $9.37 | $364,483.63 | 908,104 |
| 6 February 2024 | Zhenya LindgardtDirector | Sell Tax related | 27,997 | $8.03 | $224,815.91 | 947,003 |
| 28 March 2024 | John J. (Jay) BonifaceChief Level Officer | Sell Option/Award related | 24,474 | $9.04 | $221,244.96 | 139,771 |
| 10 June 2024 | Zhenya LindgardtDirector | Sell Tax related | 26,867 | $8.11 | $217,891.37 | 869,245 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.